22.06.2015 • NewsPeopleManaging DirectorDirector

Christophe Villain appointed Managing Director of Arkema’s Fluorogas business

Christophe Villain is being appointed Managing Director of the Fluorogas...
Christophe Villain is being appointed Managing Director of the Fluorogas business unit of French chemical manufacturer Arkema effective 1st July 2015.

Christophe Villain is being appointed Managing Director of the Fluorogas business unit of French chemical manufacturer Arkema effective 1st July 2015.
Villain is a graduate of Ecole Nationale Supérieure de Chimie in Paris. He began his career at Elf Atochem in 1987 as Polypropylene Development Engineer within the Appryl subsidiary. In 1990, he joined General Electric Plastics to head marketing in the automotive sector. In 1996, he became Head of Elf Atochem’s Polystyrene Department, and in 2001 Head of Atofina’s global Bleaching Department. In 2003, he was appointed Managing Director of Arkema’s Urea Formaldehyde Resins business unit. From 2006 to 2011, he was Managing Director of CECA, and since 2011 had been Managing Director of the PMMA (Altuglas International) business unit.

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.